{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:07:27Z","timestamp":1788786447640,"version":"build-2803163510"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bcp.2019.03.034","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T13:23:40Z","timestamp":1553693020000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Marfan syndrome: A therapeutic challenge for long-term care"],"prefix":"10.1016","volume":"164","author":[{"given":"A.H.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zaradzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Remes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kallenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.84.2.129","article-title":"Natural history of cardiovascular manifestations in Marfan syndrome","volume":"84","author":"van Karnebeek","year":"2001","journal-title":"Arch. Dis. Child."},{"issue":"15","key":"10.1016\/j.bcp.2019.03.034_b0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome","volume":"286","author":"Murdoch","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mgg3.489","article-title":"Survival, causes of death, and cardiovascular events in patients with Marfan syndrome","volume":"6","author":"Vanem","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.bcp.2019.03.034_b0025","article-title":"Marfan syndrome: improved clinical history results in expanded natural history","author":"Pyeritz","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.bcp.2019.03.034_b0030","series-title":"GeneReviews((R))","article-title":"Marfan syndrome","author":"Dietz","year":"2001"},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","article-title":"Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome","volume":"101","author":"Chung","year":"2007","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5603\/CJ.2013.0066","article-title":"The role of transforming growth factor-beta in Marfan syndrome","volume":"20","author":"Benke","year":"2013","journal-title":"Cardiol. J."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0045","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome","volume":"168","author":"Franken","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00441-014-1993-7","article-title":"Regional changes in elastic fiber organization and transforming growth factor beta signaling in aortas from a mouse model of marfan syndrome","volume":"358","author":"Howell","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020138","article-title":"Induction of macrophage chemotaxis by aortic extracts from patients with Marfan syndrome is related to elastin binding protein","volume":"6","author":"Guo","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2019.03.034_b0060","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1177\/1535370215576312","article-title":"Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1\/2","volume":"240","author":"Wang","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s004030050342","article-title":"In vitro degradation of tropoelastin by reactive oxygen species","volume":"290","author":"Hayashi","year":"1998","journal-title":"Arch. Dermatol. Res."},{"issue":"8","key":"10.1016\/j.bcp.2019.03.034_b0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","article-title":"Cardiovascular disease in women: clinical perspectives","volume":"118","author":"Garcia","year":"2016","journal-title":"Circ. Res."},{"issue":"9 Suppl","key":"10.1016\/j.bcp.2019.03.034_b0075","first-page":"I323","article-title":"Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals","volume":"112","author":"Blankstein","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0195-668X(02)00799-6","article-title":"The logistic EuroSCORE","volume":"24","author":"Roques","year":"2003","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145371","article-title":"Female gender and differences in outcome after isolated coronary artery bypass graft surgery: does age play a role?","volume":"11","author":"Arif","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bcp.2019.03.034_b0090","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.0000141593.05085.87","article-title":"Surgery for aneurysms of the aortic root: a 30-year experience","volume":"110","author":"Zehr","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2019.03.034_b0095","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/euhj.1999.1873","article-title":"Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms","volume":"21","author":"English","year":"2000","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.bcp.2019.03.034_b0100","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehq258","article-title":"Cardiovascular manifestations in men and women carrying a FBN1 mutation","volume":"31","author":"Detaint","year":"2010","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00392-016-1028-3","article-title":"Aortic events in a nationwide Marfan syndrome cohort","volume":"106","author":"Groth","year":"2017","journal-title":"Clin. Res. Cardiol."},{"issue":"10","key":"10.1016\/j.bcp.2019.03.034_b0110","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.amjcard.2005.06.094","article-title":"Aortic root growth in men and women with the Marfan's syndrome","volume":"96","author":"Meijboom","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"41","key":"10.1016\/j.bcp.2019.03.034_b0115","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur. Heart J."},{"issue":"43","key":"10.1016\/j.bcp.2019.03.034_b0120","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/eurheartj\/ehv739","article-title":"Genotype impacts survival in Marfan syndrome","volume":"37","author":"Franken","year":"2016","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.bcp.2019.03.034_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181166","article-title":"Sex, pregnancy and aortic disease in Marfan syndrome","volume":"12","author":"Renard","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bcp.2019.03.034_b0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004052","article-title":"Aortic complications associated with pregnancy in Marfan syndrome: The NHLBI National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)","volume":"5","author":"Roman","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0135","doi-asserted-by":"crossref","first-page":"H115","DOI":"10.1152\/ajpheart.00521.2014","article-title":"Hypertension overrides the protective effect of female hormones on the development of aortic aneurysm secondary to Alk5 deficiency via ERK activation","volume":"308","author":"Schmit","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0140","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.HYP.0000187016.06549.96","article-title":"Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression","volume":"46","author":"Natoli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2019.03.034_b0145","unstructured":"J.P. Habashi, E.M. Gallo, N. Huso, Y. Chen, D. Bedja, D. Huso, H.C. Dietz, A causative role for oxytocin in pregnancy-induced aortic dissection in Marfan syndrome mouse model, in: Abstract #363 Presented at the 64th Annual Meeting of the American Society of Human Genetics, San Diego,CA October 21, 2014, 2014."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0150","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jvs.2012.10.007","article-title":"The fibrillin-1 hypomorphic mgR\/mgR murine model of Marfan syndrome shows severe elastolysis in all segments of the aorta","volume":"57","author":"Schwill","year":"2013","journal-title":"J. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0155","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/CIRCGENETICS.116.001485","article-title":"International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium)","volume":"9","author":"Jondeau","year":"2016","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/jmg.2008.062844","article-title":"Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations","volume":"46","author":"Tran-Fadulu","year":"2009","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00109-007-0240-z","article-title":"Sexually dimorphic gene expression in the heart of mice and men","volume":"86","author":"Isensee","year":"2008","journal-title":"J. Mol. Med. (Berl)"},{"issue":"28","key":"10.1016\/j.bcp.2019.03.034_b0170","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1073\/pnas.1802889115","article-title":"Sex-chromosome dosage effects on gene expression in humans","volume":"115","author":"Raznahan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1 Suppl.","key":"10.1016\/j.bcp.2019.03.034_b0175","first-page":"I365","article-title":"Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome","volume":"114","author":"Ikonomidis","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.107.689208","article-title":"Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates","volume":"116","author":"Qiu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2019.03.034_b0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fphys.2017.00933","article-title":"Differences in the thoracic aorta by region and sex in a murine model of Marfan syndrome","volume":"8","author":"Jimenez-Altayo","year":"2017","journal-title":"Front. Physiol."},{"issue":"6333","key":"10.1016\/j.bcp.2019.03.034_b0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2019.03.034_b0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.2005.039669","article-title":"The molecular genetics of Marfan syndrome and related disorders","volume":"43","author":"Robinson","year":"2006","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0200","first-page":"E43","volume":"76","author":"Hiratzka","year":"2010","journal-title":"Catheter Cardiovasc. Interv."},{"issue":"Suppl 6","key":"10.1016\/j.bcp.2019.03.034_b0205","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.21037\/jtd.2017.04.69","article-title":"Strategies to prevent aortic complications in Marfan syndrome","volume":"9","author":"Sartor","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"5770","key":"10.1016\/j.bcp.2019.03.034_b0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bcp.2019.03.034_b0215","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.bcp.2019.03.034_b0220","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2018.07.051","article-title":"Losartan for the treatment of Marfan syndrome: hope fades","volume":"72","author":"Isselbacher","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.bcp.2019.03.034_b0225","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jacc.2018.07.052","article-title":"Losartan versus atenolol for prevention of aortic dilation in patients with marfan syndrome","volume":"72","author":"Teixido-Tura","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2019.03.034_b0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omtn.2017.08.014","article-title":"AP-1 oligodeoxynucleotides reduce aortic elastolysis in a murine model of Marfan syndrome","volume":"9","author":"Arif","year":"2017","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"11 Suppl.","key":"10.1016\/j.bcp.2019.03.034_b0235","first-page":"S168","article-title":"Pravastatin reduces Marfan aortic dilation","volume":"124","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bcp.2019.03.034_b0240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjcard.2013.05.081","article-title":"Effect of statin drugs on thoracic aortic aneurysms","volume":"112","author":"Stein","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","volume":"140","author":"Yang","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016250","article-title":"MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3' UTR and coding-sequence binding sites","volume":"6","author":"Ott","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bcp.2019.03.034_b0255","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13257","article-title":"Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model","volume":"5","author":"Okamura","year":"2017","journal-title":"Physiol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0260","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1096\/fj.10-174904","article-title":"OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2\/MMP-9 genes: a novel mechanism for cardiovascular diseases","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bcp.2019.03.034_b0265","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/ATVBAHA.116.307841","article-title":"Resveratrol inhibits aortic root dilatation in the Fbn1C1039G\/+ Marfan mouse model","volume":"36","author":"Hibender","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2019.03.034_b0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2017.03.010","article-title":"A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms","volume":"261","author":"Iyer","year":"2017","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12967-018-1429-3","article-title":"Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome","volume":"16","author":"Abu-Halima","year":"2018","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0280","first-page":"4","article-title":"Signalling: YAP, PTEN and miR-29 size each other up","volume":"13","author":"McCarthy","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"Pt 20","key":"10.1016\/j.bcp.2019.03.034_b0285","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0290","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3892\/mmr.2017.6844","article-title":"Rapamycin inhibits CaCl2-induced thoracic aortic aneurysm formation in rats through mTOR-mediated suppression of proinflammatory mediators","volume":"16","author":"Cao","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0295","doi-asserted-by":"crossref","first-page":"H1112","DOI":"10.1152\/ajpheart.00089.2018","article-title":"Proteomics reveals Rictor as a noncanonical TGF-beta signaling target during aneurysm progression in Marfan mice","volume":"315","author":"Parker","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","article-title":"Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms","volume":"27","author":"McCormick","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.carpath.2014.04.007","article-title":"Aortopathy in Marfan syndrome: an update","volume":"23","author":"Romaniello","year":"2014","journal-title":"Cardiovasc. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.034_b0310","doi-asserted-by":"crossref","first-page":"L661","DOI":"10.1152\/ajplung.00269.2005","article-title":"Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells","volume":"290","author":"Sturrock","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0315","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/ATVBAHA.108.163592","article-title":"AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit","volume":"28","author":"Manea","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2019.03.034_b0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2018.02.023","article-title":"Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm","volume":"118","author":"Jimenez-Altayo","year":"2018","journal-title":"Free Radical Biol. Med."},{"issue":"17","key":"10.1016\/j.bcp.2019.03.034_b0325","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","volume":"340","author":"Gott","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.bcp.2019.03.034_b0330","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur. Heart J."},{"issue":"41","key":"10.1016\/j.bcp.2019.03.034_b0335","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.111.054676","article-title":"Aortic event rate in the Marfan population: a cohort study","volume":"125","author":"Jondeau","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2019.03.034_b0345","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.23.4.338","article-title":"A technique for complete replacement of the ascending aorta","volume":"23","author":"Bentall","year":"1968","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0350","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jtcvs.2007.01.058","article-title":"Aortic root reconstruction with a bioprosthetic valved conduit: a consecutive series of 275 procedures","volume":"133","author":"Etz","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0355","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtcvs.2015.10.068","article-title":"Long-term outcomes of aortic root operations for Marfan syndrome: a comparison of Bentall versus aortic valve-sparing procedures","volume":"151","author":"Price","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0360","doi-asserted-by":"crossref","first-page":"682","DOI":"10.21037\/acs.2017.11.05","article-title":"Aortic valve sparing root surgery for Marfan syndrome","volume":"6","author":"Matalanis","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"13","key":"10.1016\/j.bcp.2019.03.034_b0365","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2015.07.041","article-title":"Outcomes of Aortic valve-sparing operations in Marfan syndrome","volume":"66","author":"David","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0370","doi-asserted-by":"crossref","first-page":"570","DOI":"10.21037\/acs.2017.11.06","article-title":"Systematic review and meta-analysis of surgical outcomes in Marfan patients undergoing aortic root surgery by composite-valve graft or valve sparing root replacement","volume":"6","author":"Flynn","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0375","first-page":"44","article-title":"Aortic valve sparing operations in aortic root aneurysms: remodeling or reimplantation?","volume":"2","author":"Tian","year":"2013","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"10","key":"10.1016\/j.bcp.2019.03.034_b0380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacc.2018.06.053","article-title":"External aortic root support to prevent aortic dilatation in patients with Marfan syndrome","volume":"72","author":"Izgi","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0385","doi-asserted-by":"crossref","first-page":"S774","DOI":"10.1016\/j.athoracsur.2006.10.085","article-title":"When should the aortic arch be replaced in Marfan patients?","volume":"83","author":"Bachet","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0390","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ejcts\/ezs705","article-title":"Should aortic arch replacement be performed during initial surgery for aortic root aneurysm in patients with Marfan syndrome?","volume":"44","author":"Schoenhoff","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.21037\/acs.2017.09.14","article-title":"Re-interventions on the thoracic and thoracoabdominal aorta in patients with Marfan syndrome","volume":"6","author":"Schoenhoff","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"13","key":"10.1016\/j.bcp.2019.03.034_b0400","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1161\/CIR.0b013e3181d47d48","volume":"121","author":"Hiratzka","year":"2010","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.bcp.2019.03.034_b0405","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/eurheartj\/ehs074","volume":"33","author":"Grabenwoger","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0410","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.athoracsur.2015.11.008","article-title":"Results of open surgical repair in patients with marfan syndrome and distal aortic dissection","volume":"101","author":"Coselli","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bcp.2019.03.034_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.05.081","article-title":"Open surgical thoracoabdominal aortic aneurysm repair: the Heidelberg experience","author":"Mkalaluh","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0420","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0002-9149(02)02290-7","article-title":"Frequency of coronary ostial aneurysms after aortic root surgery in patients with the Marfan syndrome","volume":"89","author":"Meijboom","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.034_b0425","doi-asserted-by":"crossref","first-page":"654","DOI":"10.21037\/acs.2017.11.09","article-title":"Medical management of aortic disease in Marfan syndrome","volume":"6","author":"Bin Mahmood","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0430","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0435","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MOP.0000000000000671","article-title":"Medical management of aortic disease in children with Marfan syndrome","volume":"30","author":"Lindsay","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.034_b0440","first-page":"316","article-title":"Unlicensed and off-label drug use in children before and after pediatric governmental initiatives","volume":"20","author":"Corny","year":"2015","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2019.03.034_b0445","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.drudis.2008.03.014","article-title":"Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?","volume":"13","author":"Rayburn","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2019.03.034_b0450","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.14137","article-title":"An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology","author":"Bhushan","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0455","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng.3723","article-title":"An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death","volume":"49","author":"Granata","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0460","first-page":"2","article-title":"Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles","volume":"4","author":"Fontaine","year":"2015","journal-title":"Cell Regen. (Lond)"},{"key":"10.1016\/j.bcp.2019.03.034_b0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","article-title":"Transcription factor decoy technology: a therapeutic update","volume":"144","author":"Hecker","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.bcp.2019.03.034_b0470","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/sj.gt.3302068","article-title":"Intracellular production of DNA enzyme by a novel single-stranded DNA expression vector","volume":"10","author":"Chen","year":"2003","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0475","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5387\/fms.2018-02","article-title":"Targeted therapy according to next generation sequencing-based panel sequencing","volume":"64","author":"Saito","year":"2018","journal-title":"Fukushima J. Med. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0480","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI200422399","article-title":"Determination of the molecular basis of Marfan syndrome: a growth industry","volume":"114","author":"Byers","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"4910","key":"10.1016\/j.bcp.2019.03.034_b0485","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1126\/science.2499928","article-title":"Recombinant gene expression in vivo within endothelial cells of the arterial wall","volume":"244","author":"Nabel","year":"1989","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bcp.2019.03.034_b0490","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/81176","article-title":"Gene delivery from a DNA controlled-release stent in porcine coronary arteries","volume":"18","author":"Klugherz","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.bcp.2019.03.034_b0495","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.gt.3302010","article-title":"Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent","volume":"10","author":"Takahashi","year":"2003","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.034_b0500","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.gt.3300800","article-title":"Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes","volume":"6","author":"Turunen","year":"1999","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.bcp.2019.03.034_b0505","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Parker","year":"2013","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148012","article-title":"Loss of Endothelial Barrier in Marfan Mice (mgR\/mgR) results in severe inflammation after adenoviral gene therapy","volume":"11","author":"Seppelt","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0515","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/01.CIR.85.3.1110","article-title":"Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter","volume":"85","author":"Flugelman","year":"1992","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0520","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/gt.2013.13","article-title":"Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy","volume":"20","author":"Lompre","year":"2013","journal-title":"Gene Ther."},{"issue":"20","key":"10.1016\/j.bcp.2019.03.034_b0525","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.gt.3302564","article-title":"Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation","volume":"12","author":"Denby","year":"2005","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0530","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0008-6363(97)00163-6","article-title":"Gene transfer into vascular cells using adeno-associated virus (AAV) vectors","volume":"35","author":"Maeda","year":"1997","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0535","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"Muller","year":"2003","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.034_b0540","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymthe.2003.11.006","article-title":"Development of efficient viral vectors selective for vascular smooth muscle cells","volume":"9","author":"Work","year":"2004","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2019.03.034_b0545","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/hum.2015.097","article-title":"Systemic vascular transduction by capsid mutant adeno-associated virus after intravenous injection","volume":"26","author":"Lipinski","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.034_b0550","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1357-4310(98)01326-4","article-title":"Towards an RNA-based therapy for Marfan syndrome","volume":"4","author":"Kilpatrick","year":"1998","journal-title":"Mol. Med. Today"},{"issue":"4","key":"10.1016\/j.bcp.2019.03.034_b0555","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvs.2008.04.016","article-title":"Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats","volume":"48","author":"Xiong","year":"2008","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.034_b0560","first-page":"206","article-title":"Overexpression of TIMP-2 mediated by recombinant adenovirus in rat abdominal aorta inhibits extracellular matrix degradation","volume":"2","author":"Zhao","year":"2008","journal-title":"Biosci. Trends"},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032963","article-title":"Inflammation aggravates disease severity in Marfan syndrome patients","volume":"7","author":"Radonic","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2019.03.034_b0570","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.gt.3303069","article-title":"Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice","volume":"15","author":"Qian","year":"2008","journal-title":"Gene Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:04:41Z","timestamp":1757768681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":114,"alternative-id":["S0006295219301200"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.034","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marfan syndrome: A therapeutic challenge for long-term care","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}